Trials / Completed
CompletedNCT04021589
Chemotherapy w/wo WeiLeShu in Metastatic Colorectal Cancer
A Study of Chemotherapy With WeiLeShu Versus Chemotherapy Alone in Patients With Metastatic Colorectal Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A total of 50 patients with metastatic colorectal cancer will be enrolled in the study. The patients were randomly divided into the WLS-intervention group and the control group. The two groups of patients were given the most appropriate medication according to the specific conditions of the disease. Patients in the intervention group received additional oral administration of Weileshu, a probiotics product (Tongchuang Biotechnology).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Weileshu | a probiotics products which help to rebuild homeostasis of gut microbiome |
| DRUG | Chemotherapy | chemotherapy |
Timeline
- Start date
- 2019-07-11
- Primary completion
- 2021-10-30
- Completion
- 2021-10-30
- First posted
- 2019-07-16
- Last updated
- 2023-01-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04021589. Inclusion in this directory is not an endorsement.